|

Oxaliplatin plus S-1 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Ruijin Hospital1

Indications

  • Docetaxel1
  • Stage 3 Cancer1
  • Adjuvant Chemotherapy1
  • Oxaliplatin1
  • Gastric Cancer (GC)1

Other1 trial

Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.